journal logo

Welcome to Oncogene

Publishing the latest research on the cellular and molecular biology of cancer including resistance to cancer therapies, and the development of better approaches to improving survival. 

Featured

Current issue

Volume 42 Issue 39
Contents
View all issues
Subscribe

Announcements

  • Our reviewers are essential in supporting the publication process of BMT. Their knowledge and critical evaluation is key and always appreciated. To show our thanks, we present here the profiles those awarded our 'top reviewer' accolade in 2022.

  • In this collection we highlight a selection of articles from 2022, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo).

  • Join the Oncogene Twitter Community @oncogenejournal. Follow us to keep up-to-date with the latest research and news from Oncogene. Share your views, retweet and give us feedback.

Oncogene is a Transformative Journal; authors can publish using the traditional publishing route OR via immediate gold Open Access.

Our Open Access option complies with funder and institutional requirements.

Advertisement

Browse articles

Collections

collection image

Readers Choice: The best of Oncogene 2022

In this collection we highlight a selection of articles from 2022, which top the list of the journal’s most cited, downloaded and most shared (including press coverage, blogs, Twitter, Facebook and Weibo). The articles showcase the breadth of scope and coverage that the journal consistently delivers to its readers.
Collection

Advertisement

Trending - Altmetric